The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a “very rare” side effect of the AstraZeneca COVID-19 vaccine.

(Sharecast News) - Pharma titan AstraZeneca has announced that its Wainzua nerve damage treatment has been recommended for approval in the EU. Wainzua, jointly developed with California biotech ...

The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, the company has said, months after the pharmaceutical firm ...

AstraZeneca has a single ... and next-generation IO agents such as T cell engagers and cell therapies to activate an immune response to ensure they are fully eradicated including micro-metastatic ...

After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Astrazeneca has entered into a licensing agreement, potentially worth up to $2bn (£1.5bn), with China's CPSC Pharmaceutical ...

September 11, 2023 • When we scarf down our food, we don't get a chance to properly digest or appreciate it. Lilian Cheung, a mindful eating lecturer at Harvard, shares techniques on how to slow ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-1.36%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...

Our in-depth conversation covered a wide array of topics, including her perspectives on talent leadership, staying at the forefront of innovation in a company like AstraZeneca, the organization's ...

Life Kit is here to help you get it together. Want another life hack? Try Life Kit+. You'll support the show and unlock exclusive curated playlists and sponsor-free listening. Learn more at plus ...

The year 2021 was one of big impact for pharmaceutical leader AstraZeneca, which supplied over 2.5 billion doses of COVID-19 vaccines to more than 180 countries. But when it comes to ESG reporting ...